Q

QED Therapeutics

31 employees

QED Therapeutics is a biotechnology company focused on precision medicine for FGFR-driven disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Health Care

Date founded

2018

Funding rounds raised

Total raised

$65M

from 1 investors over 1 rounds

Q

QED Therapeutics raised $65M on January 30, 2018

Investors: BridgeBio

FAQ